Use of aminoglycosides in animals in the European Union: development of resistance and impact on human and animal health
| Current version |
|
| Reference number | EMA/CVMP/AWP/721118/2014 |
| Published | 05/07/2018 |
| Keywords | Amynoglycosides, development in resistance, veterinary antimicrobial agents, antimicrobial resistance |
| Description | The purpose of the reflection paper, which was developed by EMA's Antimicrobials Working Party, and adopted by the Committee for Medicinal Products for Veterinary Use (CVMP), is to critically review the current knowledge on the usage of aminoglycosides, the development of resistance and the potential impact of this resistance on animal and human health. On this basis, the paper makes recommendations on how these medicines should be used in animals to maintain their effectiveness to treat infections in both humans and animals. |
Document history
| First version current version | Published: 05/07/2018 Published: 05/07/2018 Published: 25/07/2017
|
Related content
- Recommendations for use of aminoglycosides in animals to reduce risk of antimicrobial resistance (25/07/2017)
- Antimicrobial resistance
- Assessment of the risk to public health from antimicrobial resistance due to the use of an antimicrobial veterinary medicinal product in food-producing animals
- Product information: reference documents and guidelines
- Recommendations on the use of antibiotics in animals